Publication: Stress kinases in the development of liver steatosis and hepatocellular carcinoma.
| dc.contributor.author | Cicuéndez, Beatriz | |
| dc.contributor.author | Ruiz-Garrido, Irene | |
| dc.contributor.author | Mora, Alfonso | |
| dc.contributor.author | Sabio, Guadalupe | |
| dc.contributor.funder | Unión Europea. Comisión Europea. European Research Council (ERC) | es_ES |
| dc.contributor.funder | Fundación BBVA | es_ES |
| dc.contributor.funder | Ministerio de Economía y Competitividad (España) | es_ES |
| dc.contributor.funder | Asociación Española Contra el Cáncer | es_ES |
| dc.contributor.funder | Comunidad de Madrid (España) | es_ES |
| dc.contributor.funder | Ministerio de Ciencia, Innovación y Universidades (España) | es_ES |
| dc.contributor.funder | Fundación ProCNIC | es_ES |
| dc.date.accessioned | 2024-03-11T14:26:26Z | |
| dc.date.available | 2024-03-11T14:26:26Z | |
| dc.date.issued | 2021-08 | |
| dc.description.abstract | Non-alcoholic fatty liver disease (NAFLD) is an important component of metabolic syndrome and one of the most prevalent liver diseases worldwide. This disorder is closely linked to hepatic insulin resistance, lipotoxicity, and inflammation. Although the mechanisms that cause steatosis and chronic liver injury in NAFLD remain unclear, a key component of this process is the activation of stress-activated kinases (SAPKs), including p38 and JNK in the liver and immune system. This review summarizes findings which indicate that the dysregulation of stress kinases plays a fundamental role in the development of steatosis and are important players in inducing liver fibrosis. To avoid the development of steatohepatitis and liver cancer, SAPK activity must be tightly regulated not only in the hepatocytes but also in other tissues, including cells of the immune system. Possible cellular mechanisms of SAPK actions are discussed. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | We thank S. Bartlett for English editing. GS receives funding from the European Union Seventh Framework Programme (FP7/2007-2013) ERC 260464, the EFSD/Lilly European Diabetes Research Programme, a Leonardo Grant for Researchers and Cultural Creators from the BBVA Foundation (Investigadores-BBVA-2017) IN[17] _BBM_BAS_0066, the Ministerio de Economia y Competitividad (MINECO-FEDER SAF2016-79126-R and PID2019-104399RB-I00), the Fundación AECC (PROYE19047SABI), and the Comunidad de Madrid (IMMUNOTHERCAN-CM S2010/ BMD-2326 and B2017/BMD-3733). The CNIC is supported by the Ministerio de Ciencia, Innovación y Universidades (MCNU)Ministerio de Ciencia, Innovación y Universidades, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505). We thank our collaborators and all the students and fellows who have contributed to studies in the Sabio group over the years. We regret the inadvertent omission of important references due to space limitations | es_ES |
| dc.format.page | 101190 | es_ES |
| dc.format.volume | 50 | es_ES |
| dc.identifier.citation | Mol Metab. 2021 Aug:50:101190. | es_ES |
| dc.identifier.doi | 10.1016/j.molmet.2021.101190 | es_ES |
| dc.identifier.e-issn | 2212-8778 | es_ES |
| dc.identifier.journal | Molecular metabolism | es_ES |
| dc.identifier.pubmedID | 33588102 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/18916 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/SAF2016-79126-R | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PID2019-104399RB-I00 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PROYE19047SABI | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/IMMUNOTHERCAN-CM S2010/BMD-2326 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/B2017/BMD-3733 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/SEV-2015-0505 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/ERC/260464 | es_ES |
| dc.relation.publisherversion | 10.1016/j.molmet.2021.101190 | es_ES |
| dc.repisalud.institucion | CNIC | es_ES |
| dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Papel de las quinasas activadas por el estrés en el desarrollo de enfermedades cardiovasculares, diabetes y cáncer | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject.mesh | MAP Kinase Signaling System | es_ES |
| dc.subject.mesh | Animals | es_ES |
| dc.subject.mesh | Autophagy | es_ES |
| dc.subject.mesh | Carcinoma, Hepatocellular | es_ES |
| dc.subject.mesh | Disease Models, Animal | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | Insulin Resistance | es_ES |
| dc.subject.mesh | JNK Mitogen-Activated Protein Kinases | es_ES |
| dc.subject.mesh | Liver | es_ES |
| dc.subject.mesh | Liver Neoplasms | es_ES |
| dc.subject.mesh | Non-alcoholic Fatty Liver Disease | es_ES |
| dc.subject.mesh | Protective Agents | es_ES |
| dc.subject.mesh | p38 Mitogen-Activated Protein Kinases | es_ES |
| dc.title | Stress kinases in the development of liver steatosis and hepatocellular carcinoma. | es_ES |
| dc.type | review article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | bc42fc37-5614-4176-852f-4210784143e8 | |
| relation.isAuthorOfPublication | 7de1300f-8563-434d-b693-41b7c8c6fdd1 | |
| relation.isAuthorOfPublication.latestForDiscovery | bc42fc37-5614-4176-852f-4210784143e8 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Stress kinases_Mol Metab_2021.pdf
- Size:
- 2.01 MB
- Format:
- Adobe Portable Document Format
- Description:


